Aurinia Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Edmonton, Alberta, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
Aurinia Pharmaceuticals Inc. has filed 606 SEC EDGAR filings since 28 Feb 2014

SEC filing history

Showing 426-450 of 606 matching filings.

Per page
25
Current page
18
6-K File 001-36421

6-K

Filing date
09 Aug 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
11 Jul 2018
Reporting date
11 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
25 Jun 2018
Reporting date
25 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
22 Jun 2018
Reporting date
22 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-225538

S-8

Filing date
08 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-36421

6-K/A

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
16 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

6-K

Filing date
10 May 2018
Reporting date
31 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
10 May 2018
Reporting date
10 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SUPPL File 333-222413

PROSPECTUS SUPPLEMENT NO. 1

Filing date
06 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-222413

EFFECT filing

Filing date
29 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10/A File 333-222413

AMENDMENT NO. 1 TO FORM F-10

Filing date
26 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
15 Mar 2018
Reporting date
15 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
23 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88628

SC 13G filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
09 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
F-X File 333-222413

F-X

Filing date
04 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
04 Jan 2018
Reporting date
04 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
F-10 File 333-222413

FORM F-10

Filing date
04 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

FORM 6-K

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
14 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88628

SC 13D/A filing

Filing date
23 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-36421

AURINIA PHARMACEUTICALS INC. 6-K

Filing date
20 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .